LONG-TERM OUTCOMES, SURVIVAL PREDICTORS AND UP-FRONT TREATMENT PATTERNS IN 568 ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS FROM LATAM: IS R-CHOP STILL THE FIRST CHOICE FOR TREATING PATIENTS OLDER THAN 60 YEARS? RN de Vita; COO Reichert; HF Culler; ROd Costa; SAC Siqueira; IC Soares; V Rocha; J Pereira; LAPC Lage;

OUTCOMES OF DIFFUSE LARGE B CELL LYMPHOMA PATIENTS TREATED IN A BRAZILIAN PUBLIC CANCER CENTER ¿ A REAL WORLD EXPERIENCE OF 809 PATIENTS IN A 11 YEAR PERIOD M Bellesso; J Pereira; L Bassolli; ANR Abdo; WFS Junior; RD Velasques; AAGS Brandão; LAPC Lage; FVR Maciel; V Rocha; H Visnadi;

PRIMARY MEDIASTINAL B-CELL LYMPHOMA IN BRAZIL: INTENSIFIED REGIMEN DOESN'T SEEM TO IMPROVE OUTCOMES WHEN COMPARED TO R-CHOP IN A RESOURCE-CONSTRAINED SCENARIO ¿ A RETROSPECTIVE CHART-REVIEW STUDY RD Velasques; WF Silva-Júnior; M Bellesso; V Rocha; J Pereira;